← All organizations
Highest phase reached
Phase 4
First clinical trial
Aug 1, 2011Last known activity
Dec 1, 2016
Timeline
No events for the selected filters.
Drugs by trial phase (13 distinct, 7 trials)
Phase 4 (6 own, 0 via acquisition)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Recent trials (7)
- NCT02848820Lead sponsorPhase 4Dec 1, 2016
- NCT02883023Lead sponsorPhase 2Nov 1, 2016
- NCT02280993Lead sponsorPhase 1May 1, 2014
- NCT02087384Lead sponsorPhase 4Mar 1, 2014
- NCT01635790Lead sponsorPhase 2/Phase 3Jun 1, 2012
- NCT01184404Lead sponsorN/ASep 1, 2011
- NCT01417988Lead sponsorPhase 4Aug 1, 2011
Details
- Last known activity
- Dec 1, 2016